525 Investigating dynamic IDO-Kyn-AhR pathway-induced tumor immunosuppression using imaging modality to optimize AhR therapeutic intervention
Main Authors: | Jedd D Wolchok, Taha Merghoub, Sadna Budhu, Inna Serganova, Jonathan F Khan, Mamadou A Bah |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
Carboxyamidotriazole combined with IDO1-Kyn-AhR pathway inhibitors profoundly enhances cancer immunotherapy
by: Jing Shi, et al.
Published: (2019-09-01) -
TDO2 Promotes the EMT of Hepatocellular Carcinoma Through Kyn-AhR Pathway
by: Lei Li, et al.
Published: (2021-01-01) -
Dubosiella newyorkensis modulates immune tolerance in colitis via the L-lysine-activated AhR-IDO1-Kyn pathway
by: Yanan Zhang, et al.
Published: (2024-02-01) -
Correction: Both IDO1 and TDO contribute to the malignancy of gliomas via the Kyn–AhR–AQP4 signaling pathway
by: Lisha Du, et al.
Published: (2021-11-01) -
The Landscape of AhR Regulators and Coregulators to Fine-Tune AhR Functions
by: Marco Gargaro, et al.
Published: (2021-01-01)